Literature DB >> 17611201

Tackling medical futility in Texas.

Robert D Truog1.   

Abstract

Mesh:

Year:  2007        PMID: 17611201     DOI: 10.1056/NEJMp078109

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Medically Inappropriate or Futile Treatment: Deliberation and Justification.

Authors:  Cheryl J Misak; Douglas B White; Robert D Truog
Journal:  J Med Philos       Date:  2015-12-17

2.  End-of-life care decisions: importance of reviewing systems and limitations after 2 recent North American cases.

Authors:  Christopher M Burkle; Jeffre J Benson
Journal:  Mayo Clin Proc       Date:  2012-11       Impact factor: 7.616

3.  Is There Ever a Role for the Unilateral Do Not Attempt Resuscitation Order in Pediatric Care?

Authors:  Jonathan M Marron; Emma Jones; Joanne Wolfe
Journal:  J Pain Symptom Manage       Date:  2017-09-13       Impact factor: 3.612

4.  Licensing Surrogate Decision-Makers.

Authors:  Philip M Rosoff
Journal:  HEC Forum       Date:  2017-06

5.  A history of ethics and law in the intensive care unit.

Authors:  John M Luce; Douglas B White
Journal:  Crit Care Clin       Date:  2009-01       Impact factor: 3.598

6.  Surrogate decision makers' responses to physicians' predictions of medical futility.

Authors:  Lucas S Zier; Jeffrey H Burack; Guy Micco; Anne K Chipman; James A Frank; Douglas B White
Journal:  Chest       Date:  2009-03-24       Impact factor: 9.410

7.  The Charlie Gard case: British and American approaches to court resolution of disputes over medical decisions.

Authors:  J J Paris; J Ahluwalia; B M Cummings; M P Moreland; D J Wilkinson
Journal:  J Perinatol       Date:  2017-10-19       Impact factor: 2.521

8.  Medical indication regarding life-sustaining treatment for children: Focus groups with clinicians.

Authors:  Julia Desiree Lotz; Ralf J Jox; Christine Meurer; Gian Domenico Borasio; Monika Führer
Journal:  Palliat Med       Date:  2016-02-04       Impact factor: 4.762

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.